Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma(MM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04172467
What this trial is testing

Quality Assurance of Secondary Immunodeficiencies (SID) in CLL/MM Patients

Who this might be right for
Secondary Immunodeficiencies (SID)
AIO-Studien-gGmbH 1,086
Testing effectiveness (Phase 2)UnknownNCT00349115
What this trial is testing

TCD Followed by autoSCT for Newly Diagnosed MM Patients

Who this might be right for
Multiple Myeloma
Korean Multiple Myeloma Working Party 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT02315716
What this trial is testing

Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University College, London 281
Early research (Phase 1)Study completedNCT00091624
What this trial is testing

Doxil, Vincristine and Decadron (DVd) +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Celgene Corporation 77
Early research (Phase 1)Ended earlyNCT04570631
What this trial is testing

Study to Determine Recommended Phase 2 Dose of Intravenous (IV) Eftozanermin Alfa in Combination With IV or Subcutaneous (SC) Bortezomib and Oral Dexamethasone Tablet and to Assess Change in Disease Symptoms in Adult Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
AbbVie 4
Early research (Phase 1)Study completedNCT02426723
What this trial is testing

Clinical Study of CWP232291 in Relapsed or Refractory Myeloma Patients

Who this might be right for
Multiple Myeloma
JW Pharmaceutical 25
Not applicableStudy completedNCT06592222
What this trial is testing

Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma as Compared With Standard of Care Therapies

Who this might be right for
Multiple Myeloma
Pfizer 4
Testing effectiveness (Phase 2)Study completedNCT01148108
What this trial is testing

Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma

Who this might be right for
Mantle Cell LymphomaB Cell LymphomaMultiple Myeloma
Telik 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140162
What this trial is testing

Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based Therapy

Who this might be right for
Multiple Myeloma
University of Michigan Rogel Cancer Center 57
Not applicableNot Yet RecruitingNCT07740317
What this trial is testing

Neurocognitive Trajectories After BCMA CAR-T

Who this might be right for
Multiple Myeloma (MM)CART TherapyRefractory Multiple Myeloma (RRMM)
Wake Forest University Health Sciences 50
Early research (Phase 1)Study completedNCT04557150
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Forimtamig in Participants With Relapsed or Refractory Multiple Myeloma (r/r MM)

Who this might be right for
Multiple Myeloma
Hoffmann-La Roche 225
Testing effectiveness (Phase 2)Ended earlyNCT03288493
What this trial is testing

P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Poseida Therapeutics, Inc. 105
Testing effectiveness (Phase 2)Study completedNCT00691704
What this trial is testing

Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy

Who this might be right for
Multiple Myeloma
Cristina Gasparetto 18
Large-scale testing (Phase 3)Active Not RecruitingNCT03948035
What this trial is testing

Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM

Who this might be right for
Newly Diagnosed Multiple Myeloma
Wuerzburg University Hospital 576
Early research (Phase 1)Ended earlyNCT02931110
What this trial is testing

Study of IV CBL0137 in Previously Treated Hematological Subjects

Who this might be right for
Hematological Malignancies
Incuron 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT04717700
What this trial is testing

Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients

Who this might be right for
Multiple Myeloma
Ida Bruun Kristensen 50
Not applicableLooking for participantsNCT05947136
What this trial is testing

PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70.

Who this might be right for
Multiple MyelomaComplication
Centre Leon Berard 204
Not applicableLooking for participantsNCT07014865
What this trial is testing

Factors Associated With Health-related Quality of Life and Social Participation of Patients With Multiple Myeloma and Their Caregivers

Who this might be right for
Multiple Myeloma (MM)Hematologic Neoplasm
Azienda USL Reggio Emilia - IRCCS 190
Early research (Phase 1)Study completedNCT03263637
What this trial is testing

Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies

Who this might be right for
Relapsed or Refractory Haematological Malignancies IncludingAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+8 more
AstraZeneca 44
Large-scale testing (Phase 3)Study completedNCT00633542
What this trial is testing

Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM)

Who this might be right for
Multiple Myeloma
Università Politecnica delle Marche 103
Next Page